Persica Pharmaceuticals will advance its antibiotic-based drug to registrational studies after a Phase Ib study found that the therapy alleviated lower back pain in patients. The UK-based biotech ...
Persica is looking ahead to registrational trials after its antibiotic therapy met the primary endpoint in a Phase Ib trial. Image credit: Shutterstock / New Africa. Persica Pharmaceuticals will ...
The most common lilac is Syringa vulgaris, or tree lilac. Native to east Asia and south-east Europe, it was much loved by the Edwardians and was widely grown in suburban gardens before going out of ...
Persica Pharmaceuticals said it has promising Phase 1b results that support its approach of using a two-dose antibiotic to treat a subset of patients with … ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback